Stem Cell Transparency Sought
|
Friday, January 29, 2010 |
An oversight committee Tuesday urged the bond-funded California Institute for Regenerative Medicine to improve its transparency and accountability. CIRM was created as part of a 2004 ballot measure that authorized $3 billion in state general obligation bonds to finance stem-cell medical research.
